Credit Suisse Ag Bausch Health Companies Inc. Call Options Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $1.58 Million - $2 Million	-68,900 Reduced 70.88%	28,300 $781,000
Q3 2021 Nov 12, 2021	SELL	$25.04 - $30.06 $52,584 - $63,126	-2,100 Reduced 2.11%	97,200 $2.71 Million
Q1 2021 May 14, 2021	BUY	$21.37 - $34.38 $544,935 - $876,690	25,500 Added 34.55%	99,300 $3.15 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $721,101 - $994,752	47,100 Added 176.4%	73,800 $1.54 Million
Q3 2020 Nov 13, 2020	BUY	$14.88 - $20.13 $397,296 - $537,471	26,700 New	26,700 $415,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.66B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.